![]() Empty Capsules Market by Type (Gelatin, Non-gelatin), Functionality (Immediate-Release, Sustained-Release, Delayed Release), Therapeutic Application, End User (Pharmaceutical, Nutraceutical, Cosmetic, Reference Laboratories) & Region - Global Forecasts to 2028
The global empty capsules market size is projected to reach USD 4.9 billion by 2028 from USD 3.2 billion in 2023, at a CAGR of 9.3% during the forecast period. Factors such as increasing use of nut... もっと見る
日本語のページは自動翻訳を利用し作成しています。
SummaryThe global empty capsules market size is projected to reach USD 4.9 billion by 2028 from USD 3.2 billion in 2023, at a CAGR of 9.3% during the forecast period. Factors such as increasing use of nutraceuticals and benefits associated with empty capsules, are driving the market growth at a faster pace.“The non-gelatin capsules segment is likely to grow at highest CAGR during the forecast period of 2023-2028.” On the basis of type, the empty capsules market is segmented into gelatin capsules, and non-gelatin capsules. The non-gelatin capsules segment is projected to grow at the highest CAGR during the forecast period. The growth is attributed to increasing demand of vegetarian products. This is likely to have a positive impact on segmental growth. “The immediate-release capsules segment is expected to hold a dominant share in 2023.” Based on the functionality, the market is segmented into immediate-release capsules, sustained-release capsules, and delayed-release capsules. The immediate release capsules segment is expected to grow at a faster pace during the forecast period due to its advantages such as higher bioavailability, easy digestion, and low cost. “In 2022, the antibiotic & antibacterial drugs segment held a dominant share.” Based on therapeutic application, the empty capsules market is segmented into antibiotic & antibacterial drugs, dietary supplements, antacid & antiflatulent preparations, antianemic preparations, anti-inflammatory drugs, cardiovascular therapy drugs, cough & cold drugs, and other therapeutic applications. The antibiotic & antibacterial drugs segment held a dominant share of the empty capsules market. Development of new antibiotics in capsule dosage form to project the market growth. “The nutraceutical industry segment is likely to grow at highest CAGR during the forecast period of 2023-2028.” Based on end user, the empty capsules market is segmented into pharmaceutical industry, nutraceutical industry, cosmetic industry, and reference laboratories. The nutraceutical industry segment to grow at the highest CAGR during the forecast period. The growing use of dietary supplements is one of the major factors anticipated to project market growth. “Asia Pacific region is likely to grow at faster pace.” The empty capsules market is divided into North America, Europe, the Asia Pacific, Latin America, and the Middle East & Africa. In 2022, North America accounted for the dominant share of empty capsules market. The dominance of the region is attributable to various factors such as the presence of dominant and key market players in the region coupled with increasing use of dietary supplements. Asia Pacific region is likely to grow at a faster pace owing to various factors such as the low cost of manufacturing, rising scientific research in the region, and the emergence of new market players in the empty capsules market. The primary interviews conducted for this report can be categorized as follows: • By Respondent: Supply Side- 90%, and Demand Side - 10% • By Designation (Supply Side): Managers - 35%, CXOs & Directors - 20%, Executives- 45% • By Region: North America -20%, Europe -25%, Asia-Pacific -40%, Latin America -10%, and Middle East and Africa -5% Lists of Companies Profiled in the Report: • Capsugel (US) • ACG Worldwide (India) • Mitsubishi Chemical Holding Corporation (US) • CapsCanada Corporation (Canada) • Natural Capsules (India) • Suheung Co., Ltd. (South Korea) • Nectar Lifesciences Ltd. (India) • Qingdao Yiqing Medicinal Capsule (China) • Shanxi Guangsheng Medicinal Capsule (China) • Health Caps India (India) • Medi-Caps (India) • Snail Pharma Industry (China) • Roxlor (US) • Sunil Healthcare (India) • BioCaps Enterprise (US) • Bright Pharma Caps (US) • Comed Chemicals (India) • Saviour Caps (India) • Fortcaps Healthcare (India) • Shaoxing Zhongya Capsule (China) • Erawat Pharma (India) • Farmacapsulas (Colombia) • Zhejiang Yuexi Capsule (Taiwan) • LFA Machines Oxfords (US) • Shaoxing Kangke (China) • Shree Pharma Caps (India) Research Coverage: This report provides a detailed picture of the empty capsules market. It aims at estimating the size and future growth potential of the market across different segments, such as type, functionality, therapeutic application, end user, and region. The report also includes an in-depth competitive analysis of the key market players, along with their company profiles, recent developments, and key market strategies. Key Benefits of Buying the Report: The report will help market leaders/new entrants by providing them with the closest approximations of the revenue numbers for the overall empty capsules market and its subsegments. It will also help stakeholders better understand the competitive landscape and gain more insights to better position their business and make suitable go-to-market strategies. This report will enable stakeholders to understand the market's pulse and provide them with information on the key market drivers, restraints, opportunities, and challenges. Table of Contents1 INTRODUCTION 331.1 STUDY OBJECTIVES 33 1.2 MARKET DEFINITION 33 1.2.1 INCLUSIONS AND EXCLUSIONS 34 1.3 MARKET SCOPE 34 FIGURE 1 EMPTY CAPSULES MARKET SEGMENTATION 34 1.3.1 YEARS CONSIDERED 35 1.4 CURRENCY CONSIDERED 35 1.5 LIMITATIONS 35 1.6 STAKEHOLDERS 36 1.7 SUMMARY OF CHANGES 36 1.7.1 RECESSION IMPACT 36 2 RESEARCH METHODOLOGY 37 2.1 RESEARCH APPROACH 37 FIGURE 2 RESEARCH DESIGN 37 2.1.1 SECONDARY RESEARCH 38 2.1.2 PRIMARY RESEARCH 38 FIGURE 3 EMPTY CAPSULES MARKET: PRIMARY RESPONDENTS 39 2.2 MARKET ESTIMATION METHODOLOGY 39 FIGURE 4 EMPTY CAPSULES MARKET SIZE ESTIMATION, BY VALUE (2022) 39 FIGURE 5 MARKET SIZE ESTIMATION: APPROACH 1 (COMPANY REVENUE ANALYSIS-BASED ESTIMATION), 2022 40 FIGURE 6 MARKET VOLUME ESTIMATION, 2022 40 2.2.1 INSIGHTS FROM PRIMARY EXPERTS 41 FIGURE 7 INSIGHTS ON EMPTY CAPSULES MARKET FROM PRIMARY EXPERTS 41 2.3 MARKET GROWTH RATE PROJECTIONS 42 FIGURE 8 EMPTY CAPSULES MARKET (DEMAND SIDE): GROWTH ANALYSIS OF DEMAND-SIDE FACTORS 43 2.4 DATA TRIANGULATION 44 FIGURE 9 DATA TRIANGULATION METHODOLOGY 44 2.5 RESEARCH ASSUMPTIONS 45 2.6 RISK ANALYSIS 45 3 EXECUTIVE SUMMARY 46 FIGURE 10 EMPTY CAPSULES MARKET, BY TYPE, 2023 VS. 2028 (USD MILLION) 46 FIGURE 11 EMPTY CAPSULES MARKET, BY FUNCTIONALITY, 2023 VS. 2028 (USD MILLION) 47 FIGURE 12 EMPTY CAPSULES MARKET, BY THERAPEUTIC APPLICATION, 2023 VS. 2028 (USD MILLION) 47 FIGURE 13 EMPTY CAPSULES MARKET, BY END USER, 2023 VS. 2028 (USD MILLION) 48 FIGURE 14 GEOGRAPHICAL SNAPSHOT OF EMPTY CAPSULES MARKET 49 4 PREMIUM INSIGHTS 50 4.1 EMPTY CAPSULES MARKET OVERVIEW 50 FIGURE 15 INCREASING DEMAND FOR NUTRACEUTICALS TO DRIVE GROWTH 50 4.2 NORTH AMERICA: EMPTY CAPSULES MARKET, BY TYPE AND COUNTRY (2022) 50 FIGURE 16 GELATIN CAPSULES ACCOUNTED FOR LARGEST MARKET SHARE IN 2022 50 4.3 EMPTY CAPSULES MARKET SHARE, BY APPLICATION, 2023 VS. 2028 51 FIGURE 17 ANTIBIOTIC AND ANTIBACTERIAL DRUGS SEGMENT TO DOMINATE MARKET DURING FORECAST PERIOD 51 4.4 EMPTY CAPSULES MARKET: GEOGRAPHIC GROWTH OPPORTUNITIES 51 FIGURE 18 ASIA PACIFIC TO REGISTER HIGHEST GROWTH DURING FORECAST PERIOD 51 5 MARKET OVERVIEW 52 5.1 INTRODUCTION 52 5.2 MARKET DYNAMICS 52 FIGURE 19 EMPTY CAPSULES MARKET: DRIVERS, RESTRAINTS, OPPORTUNITIES, AND CHALLENGES 52 TABLE 1 EMPTY CAPSULES MARKET: IMPACT ANALYSIS OF DRIVERS, RESTRAINTS, OPPORTUNITIES, AND CHALLENGES 53 5.2.1 DRIVERS 53 5.2.1.1 Increasing demand for nutraceuticals 53 5.2.1.2 Growth in pharmaceutical market and increasing number of clinical trials and R&D activities 54 5.2.1.3 Advancements in capsule delivery technologies 54 5.2.1.4 Benefits of capsules over other dosage forms 55 5.2.2 RESTRAINTS 55 5.2.2.1 Cultural practices and dietary restrictions 55 5.2.3 OPPORTUNITIES 55 5.2.3.1 Expansion of capsule production in emerging countries 55 5.2.3.2 Development of halal gelatin and vegetarian capsules 56 5.2.4 CHALLENGES 57 5.2.4.1 Rising prices and lower availability of raw materials in gelatin industry 57 5.3 TRENDS/DISRUPTIONS IMPACTING CUSTOMERS’ BUSINESSES 58 FIGURE 20 REVENUE SHIFT AND NEW REVENUE POCKETS 58 5.4 PRICING ANALYSIS 58 TABLE 2 AVERAGE PRICE OF EMPTY CAPSULES, BY REGION (2022) 58 5.5 TECHNOLOGY ANALYSIS 59 5.5.1 ENTERIC CAPSULE TECHNOLOGIES 59 5.5.2 PROTEIN DELIVERY CAPSULE TECHNOLOGIES 59 5.6 VALUE CHAIN ANALYSIS 60 FIGURE 21 EMPTY CAPSULES MARKET: VALUE CHAIN ANALYSIS 60 5.7 ECOSYSTEM ANALYSIS 61 FIGURE 22 ECOSYSTEM ANALYSIS: EMPTY CAPSULES MARKET 61 TABLE 3 ROLE IN ECOSYSTEM 62 5.8 PORTER’S FIVE FORCES ANALYSIS 62 TABLE 4 EMPTY CAPSULES MARKET: PORTER’S FIVE FORCES ANALYSIS 62 5.8.1 THREAT OF NEW ENTRANTS 62 5.8.2 THREAT OF SUBSTITUTES 63 5.8.3 BARGAINING POWER OF SUPPLIERS 63 5.8.4 BARGAINING POWER OF BUYERS 63 5.8.5 INTENSITY OF COMPETITIVE RIVALRY 63 5.9 KEY STAKEHOLDERS AND BUYING CRITERIA 63 FIGURE 23 INFLUENCE OF STAKEHOLDERS ON BUYING PROCESS OF EMPTY CAPSULES 63 FIGURE 24 KEY BUYING CRITERIA FOR EMPTY CAPSULES 64 5.10 PATENT ANALYSIS 65 FIGURE 25 PATENT APPLICATIONS RELATED TO EMPTY CAPSULES, JANUARY 2012–MARCH 2023 65 TABLE 5 LIST OF FEW PATENTS IN EMPTY CAPSULES MARKET 66 5.11 TRADE ANALYSIS 67 TABLE 6 EXPORT DATA FOR HS CODE 960200 (TOP 10 COUNTRIES) 67 TABLE 7 IMPORT DATA FOR HS CODE 960200 (TOP 10 COUNTRIES) 67 5.12 REGULATORY ANALYSIS 68 5.13 PHARMACEUTICAL GELATIN MARKET 70 5.14 INDUSTRY TRENDS 70 5.14.1 RISING DEMAND FOR EMPTY CAPSULES IN NUTRACEUTICAL AND COSMETICS INDUSTRIES 70 5.14.2 GROWING DEMAND AND ADOPTION OF VEGETARIAN/NON-GELATIN CAPSULES 71 6 EMPTY CAPSULES MARKET, BY TYPE 72 6.1 INTRODUCTION 73 TABLE 8 EMPTY CAPSULES MARKET, BY TYPE, 2021–2028 (USD MILLION) 73 TABLE 9 EMPTY CAPSULES MARKET, BY TYPE, 2021–2028 (BILLION UNITS) 73 6.2 GELATIN CAPSULES 74 TABLE 10 GELATIN CAPSULES MARKET, BY TYPE, 2021–2028 (USD MILLION) 74 TABLE 11 GELATIN CAPSULES MARKET, BY REGION, 2021–2028 (USD MILLION) 75 TABLE 12 GELATIN CAPSULES MARKET, BY REGION, 2021–2028 (BILLION UNITS) 75 TABLE 13 NORTH AMERICA: GELATIN CAPSULES MARKET, BY COUNTRY, 2021–2028 (USD MILLION) 75 TABLE 14 EUROPE: GELATIN CAPSULES MARKET, BY COUNTRY, 2021–2028 (USD MILLION) 76 TABLE 15 ASIA PACIFIC: GELATIN CAPSULES MARKET, BY COUNTRY, 2021–2028 (USD MILLION) 76 6.2.1 PORCINE GELATIN 76 6.2.1.1 Porcine gelatin segment to dominate market 76 TABLE 16 PORCINE GELATIN CAPSULES MARKET, BY REGION, 2021–2028 (USD MILLION) 77 TABLE 17 NORTH AMERICA: PORCINE GELATIN CAPSULES MARKET, BY COUNTRY, 2021–2028 (USD MILLION) 77 TABLE 18 EUROPE: PORCINE GELATIN CAPSULES MARKET, BY COUNTRY, 2021–2028 (USD MILLION) 78 TABLE 19 ASIA PACIFIC: PORCINE GELATIN CAPSULES MARKET, BY COUNTRY, 2021–2028 (USD MILLION) 78 6.2.2 BOVINE-DERIVED GELATIN 78 6.2.2.1 Bovine-derived gelatin widely accepted in halal pharmaceuticals market 78 TABLE 20 BOVINE-DERIVED GELATIN CAPSULES MARKET, BY REGION, 2021–2028 (USD MILLION) 79 TABLE 21 NORTH AMERICA: BOVINE-DERIVED GELATIN CAPSULES MARKET, BY COUNTRY, 2021–2028 (USD MILLION) 79 TABLE 22 EUROPE: BOVINE-DERIVED GELATIN CAPSULES MARKET, BY COUNTRY, 2021–2028 (USD MILLION) 80 TABLE 23 ASIA PACIFIC: BOVINE-DERIVED GELATIN CAPSULES MARKET, BY COUNTRY, 2021–2028 (USD MILLION) 80 6.2.3 BONE MEAL 80 6.2.3.1 Bone meal gelatin gained importance in recent years 80 TABLE 24 BONE MEAL GELATIN CAPSULES MARKET, BY REGION, 2021–2028 (USD MILLION) 81 TABLE 25 NORTH AMERICA: BONE MEAL GELATIN CAPSULES MARKET, BY COUNTRY, 2021–2028 (USD MILLION) 81 TABLE 26 EUROPE: BONE MEAL GELATIN CAPSULES MARKET, BY COUNTRY, 2021–2028 (USD MILLION) 82 TABLE 27 ASIA PACIFIC: BONE MEAL GELATIN CAPSULES MARKET, BY COUNTRY, 2021–2028 (USD MILLION) 82 6.2.4 OTHER GELATIN SOURCES 82 TABLE 28 OTHER GELATIN SOURCE CAPSULES MARKET, BY REGION, 2021–2028 (USD MILLION) 83 TABLE 29 NORTH AMERICA: OTHER GELATIN SOURCE CAPSULES MARKET, BY COUNTRY, 2021–2028 (USD MILLION) 83 TABLE 30 EUROPE: OTHER GELATIN SOURCE CAPSULES MARKET, BY COUNTRY, 2021–2028 (USD MILLION) 84 TABLE 31 ASIA PACIFIC: OTHER GELATIN SOURCE CAPSULES MARKET, BY COUNTRY, 2021–2028 (USD MILLION) 84 6.3 NON-GELATIN CAPSULES 84 TABLE 32 NON-GELATIN CAPSULES MARKET, BY TYPE, 2021–2028 (USD MILLION) 85 TABLE 33 NON-GELATIN CAPSULES MARKET, BY REGION, 2021–2028 (USD MILLION) 85 TABLE 34 NON-GELATIN CAPSULES MARKET, BY REGION, 2021–2028 (BILLION UNITS) 86 TABLE 35 NORTH AMERICA: NON-GELATIN CAPSULES MARKET, BY COUNTRY, 2021–2028 (USD MILLION) 86 TABLE 36 EUROPE: NON-GELATIN CAPSULES MARKET, BY COUNTRY, 2021–2028 (USD MILLION) 86 TABLE 37 ASIA PACIFIC: NON-GELATIN CAPSULES MARKET, BY COUNTRY, 2021–2028 (USD MILLION) 87 6.3.1 HYDROXYPROPYL METHYLCELLULOSE 87 6.3.1.1 HPMC dominates non-gelatin capsules market 87 TABLE 38 HYDROXYPROPYL METHYLCELLULOSE CAPSULES MARKET, BY REGION, 2021–2028 (USD MILLION) 88 TABLE 39 NORTH AMERICA: HYDROXYPROPYL METHYLCELLULOSE CAPSULES MARKET, BY COUNTRY, 2021–2028 (USD MILLION) 88 TABLE 40 EUROPE: HYDROXYPROPYL METHYLCELLULOSE CAPSULES MARKET, BY COUNTRY, 2021–2028 (USD MILLION) 89 TABLE 41 ASIA PACIFIC: HYDROXYPROPYL METHYLCELLULOSE CAPSULES MARKET, BY COUNTRY, 2021–2028 (USD MILLION) 89 6.3.2 PULLULAN AND STARCH 89 6.3.2.1 High manufacturing costs offset advantageous aspects of pullulan and starch 89 TABLE 42 PULLULAN AND STARCH CAPSULES MARKET, BY REGION, 2021–2028 (USD MILLION) 90 TABLE 43 NORTH AMERICA: PULLULAN AND STARCH CAPSULES MARKET, BY COUNTRY, 2021–2028 (USD MILLION) 90 TABLE 44 EUROPE: PULLULAN AND STARCH CAPSULES MARKET, BY COUNTRY, 2021–2028 (USD MILLION) 91 TABLE 45 ASIA PACIFIC: PULLULAN AND STARCH CAPSULES MARKET, BY COUNTRY, 2021–2028 (USD MILLION) 91 7 EMPTY CAPSULES MARKET, BY FUNCTIONALITY 92 7.1 INTRODUCTION 93 TABLE 46 EMPTY CAPSULES MARKET, BY FUNCTIONALITY, 2021–2028 (USD MILLION) 93 7.2 IMMEDIATE-RELEASE CAPSULES 93 7.2.1 INCREASING APPLICATIONS OF IMMEDIATE-RELEASE CAPSULES TO PROPEL MARKET 93 TABLE 47 IMMEDIATE-RELEASE CAPSULES MARKET, BY REGION, 2021–2028 (USD MILLION) 94 TABLE 48 NORTH AMERICA: IMMEDIATE-RELEASE CAPSULES MARKET, BY COUNTRY, 2021–2028 (USD MILLION) 94 TABLE 49 EUROPE: IMMEDIATE-RELEASE CAPSULES MARKET, BY COUNTRY, 2021–2028 (USD MILLION) 94 TABLE 50 ASIA PACIFIC: IMMEDIATE-RELEASE CAPSULES MARKET, BY COUNTRY, 2021–2028 (USD MILLION) 95 7.3 SUSTAINED-RELEASE CAPSULES 95 7.3.1 RISING USE OF SUSTAINED-RELEASE FORMULATIONS IN TREATING CHRONIC DISEASES TO DRIVE MARKET 95 TABLE 51 SUSTAINED-RELEASE CAPSULES MARKET, BY REGION, 2021–2028 (USD MILLION) 96 TABLE 52 NORTH AMERICA: SUSTAINED-RELEASE CAPSULES MARKET, BY COUNTRY, 2021–2028 (USD MILLION) 96 TABLE 53 EUROPE: SUSTAINED-RELEASE CAPSULES MARKET, BY COUNTRY, 2021–2028 (USD MILLION) 97 TABLE 54 ASIA PACIFIC: SUSTAINED-RELEASE CAPSULES MARKET, BY COUNTRY, 2021–2028 (USD MILLION) 97 7.4 DELAYED-RELEASE CAPSULES 97 7.4.1 GROWING PREFERENCE FOR TARGETED DRUG DELIVERY TO FUEL MARKET GROWTH 97 TABLE 55 DELAYED-RELEASE CAPSULES MARKET, BY REGION, 2021–2028 (USD MILLION) 98 TABLE 56 NORTH AMERICA: DELAYED-RELEASE CAPSULES MARKET, BY COUNTRY, 2021–2028 (USD MILLION) 99 TABLE 57 EUROPE: DELAYED-RELEASE CAPSULES MARKET, BY COUNTRY, 2021–2028 (USD MILLION) 99 TABLE 58 ASIA PACIFIC: DELAYED-RELEASE CAPSULES MARKET, BY COUNTRY, 2021–2028 (USD MILLION) 99 8 EMPTY CAPSULES MARKET, BY THERAPEUTIC APPLICATION 100 8.1 INTRODUCTION 101 TABLE 59 EMPTY CAPSULES MARKET, BY THERAPEUTIC APPLICATION, 2021–2028 (USD MILLION) 101 8.2 ANTIBIOTIC AND ANTIBACTERIAL DRUGS 101 8.2.1 EMERGENCE OF NOVEL ANTIBIOTICS IN CAPSULE FORM AND INCREASING INCIDENCE OF INFECTIOUS DISEASES TO DRIVE MARKET 101 TABLE 60 EMPTY CAPSULES MARKET FOR ANTIBIOTIC AND ANTIBACTERIAL DRUGS, BY REGION, 2021–2028 (USD MILLION) 102 TABLE 61 NORTH AMERICA: EMPTY CAPSULES MARKET FOR ANTIBIOTIC AND ANTIBACTERIAL DRUGS, BY COUNTRY, 2021–2028 (USD MILLION) 102 TABLE 62 EUROPE: EMPTY CAPSULES MARKET FOR ANTIBIOTIC AND ANTIBACTERIAL DRUGS, BY COUNTRY, 2021–2028 (USD MILLION) 103 TABLE 63 ASIA PACIFIC: EMPTY CAPSULES MARKET FOR ANTIBIOTIC AND ANTIBACTERIAL DRUGS, BY COUNTRY, 2021–2028 (USD MILLION) 103 8.3 DIETARY SUPPLEMENTS 103 8.3.1 RISING DEMAND FOR DIETARY SUPPLEMENTS TO SUPPORT GROWTH 103 TABLE 64 EMPTY CAPSULES MARKET FOR DIETARY SUPPLEMENTS, BY REGION, 2021–2028 (USD MILLION) 104 TABLE 65 NORTH AMERICA: EMPTY CAPSULES MARKET FOR DIETARY SUPPLEMENTS, BY COUNTRY, 2021–2028 (USD MILLION) 104 TABLE 66 EUROPE: EMPTY CAPSULES MARKET FOR DIETARY SUPPLEMENTS, BY COUNTRY, 2021–2028 (USD MILLION) 105 TABLE 67 ASIA PACIFIC: EMPTY CAPSULES MARKET FOR DIETARY SUPPLEMENTS, BY COUNTRY, 2021–2028 (USD MILLION) 105 8.4 ANTACID AND ANTIFLATULENT PREPARATIONS 105 8.4.1 INCREASING DEMAND FOR GASTROINTESTINAL FORMULATIONS TO DRIVE MARKET 105 TABLE 68 EMPTY CAPSULES MARKET FOR ANTACID AND ANTIFLATULENT PREPARATIONS, BY REGION, 2021–2028 (USD MILLION) 106 TABLE 69 NORTH AMERICA: EMPTY CAPSULES MARKET FOR ANTACID AND ANTIFLATULENT PREPARATIONS, BY COUNTRY, 2021–2028 (USD MILLION) 106 TABLE 70 EUROPE: EMPTY CAPSULES MARKET FOR ANTACID AND ANTIFLATULENT PREPARATIONS, BY COUNTRY, 2021–2028 (USD MILLION) 107 TABLE 71 ASIA PACIFIC: EMPTY CAPSULES MARKET FOR ANTACID AND ANTIFLATULENT PREPARATIONS, BY COUNTRY, 2021–2028 (USD MILLION) 107 8.5 ANTIANEMIC PREPARATIONS 107 8.5.1 RISING INCIDENCE OF ANEMIA WORLDWIDE TO DRIVE GROWTH 107 TABLE 72 EMPTY CAPSULES MARKET FOR ANTIANEMIC PREPARATIONS, BY REGION, 2021–2028 (USD MILLION) 108 TABLE 73 NORTH AMERICA: EMPTY CAPSULES MARKET FOR ANTIANEMIC PREPARATIONS, BY COUNTRY, 2021–2028 (USD MILLION) 108 TABLE 74 EUROPE: EMPTY CAPSULES MARKET FOR ANTIANEMIC PREPARATIONS, BY COUNTRY, 2021–2028 (USD MILLION) 109 TABLE 75 ASIA PACIFIC: EMPTY CAPSULES MARKET FOR ANTIANEMIC PREPARATIONS, BY COUNTRY, 2021–2028 (USD MILLION) 109 8.6 ANTI-INFLAMMATORY DRUGS 109 8.6.1 RISING EMPHASIS ON GENERICS TO FAVOR MARKET GROWTH 109 TABLE 76 EMPTY CAPSULES MARKET FOR ANTI-INFLAMMATORY DRUGS, BY REGION, 2021–2028 (USD MILLION) 110 TABLE 77 NORTH AMERICA: EMPTY CAPSULES MARKET FOR ANTI-INFLAMMATORY DRUGS, BY COUNTRY, 2021–2028 (USD MILLION) 110 TABLE 78 EUROPE: EMPTY CAPSULES MARKET FOR ANTI-INFLAMMATORY DRUGS, BY COUNTRY, 2021–2028 (USD MILLION) 111 TABLE 79 ASIA PACIFIC: EMPTY CAPSULES MARKET FOR ANTI-INFLAMMATORY DRUGS, BY COUNTRY, 2021–2028 (USD MILLION) 111 8.7 CARDIOVASCULAR THERAPY DRUGS 111 8.7.1 RISING PREVALENCE OF CARDIOVASCULAR DISEASES TO CONTRIBUTE TO MARKET GROWTH 111 TABLE 80 EMPTY CAPSULES MARKET FOR CARDIOVASCULAR THERAPY DRUGS, BY REGION, 2021–2028 (USD MILLION) 112 TABLE 81 NORTH AMERICA: EMPTY CAPSULES MARKET FOR CARDIOVASCULAR THERAPY DRUGS, BY COUNTRY, 2021–2028 (USD MILLION) 112 TABLE 82 EUROPE: EMPTY CAPSULES MARKET FOR CARDIOVASCULAR THERAPY DRUGS, BY COUNTRY, 2021–2028 (USD MILLION) 113 TABLE 83 ASIA PACIFIC: EMPTY CAPSULES MARKET FOR CARDIOVASCULAR THERAPY DRUGS, BY COUNTRY, 2021–2028 (USD MILLION) 113 8.8 COUGH AND COLD DRUGS 113 8.8.1 GROWING ADOPTION OF OTC FORMULATIONS AND SELF-MEDICATION PRACTICES TO DRIVE GROWTH 113 TABLE 84 EMPTY CAPSULES MARKET FOR COUGH AND COLD DRUGS, BY REGION, 2021–2028 (USD MILLION) 114 TABLE 85 NORTH AMERICA: EMPTY CAPSULES MARKET FOR COUGH AND COLD DRUGS, BY COUNTRY, 2021–2028 (USD MILLION) 114 TABLE 86 EUROPE: EMPTY CAPSULES MARKET FOR COUGH AND COLD DRUGS, BY COUNTRY, 2021–2028 (USD MILLION) 115 TABLE 87 ASIA PACIFIC: EMPTY CAPSULES MARKET FOR COUGH AND COLD DRUGS, BY COUNTRY, 2021–2028 (USD MILLION) 115 8.9 OTHER THERAPEUTIC APPLICATIONS 115 TABLE 88 EMPTY CAPSULES MARKET FOR OTHER THERAPEUTIC APPLICATIONS, BY REGION, 2021–2028 (USD MILLION) 116 TABLE 89 NORTH AMERICA: EMPTY CAPSULES MARKET FOR OTHER THERAPEUTIC APPLICATIONS, BY COUNTRY, 2021–2028 (USD MILLION) 116 TABLE 90 EUROPE: EMPTY CAPSULES MARKET FOR OTHER THERAPEUTIC APPLICATIONS, BY COUNTRY, 2021–2028 (USD MILLION) 117 TABLE 91 ASIA PACIFIC: EMPTY CAPSULES MARKET FOR OTHER THERAPEUTIC APPLICATIONS, BY COUNTRY, 2021–2028 (USD MILLION) 117 9 EMPTY CAPSULES MARKET, BY END USER 118 9.1 INTRODUCTION 119 TABLE 92 EMPTY CAPSULES MARKET, BY END USER, 2021–2028 (USD MILLION) 119 9.2 PHARMACEUTICAL INDUSTRY 119 9.2.1 INCREASING EMPHASIS ON DRUG DEVELOPMENT TO DRIVE GROWTH 119 TABLE 93 EMPTY CAPSULES MARKET FOR PHARMACEUTICAL INDUSTRY, BY REGION, 2021–2028 (USD MILLION) 120 TABLE 94 NORTH AMERICA: EMPTY CAPSULES MARKET FOR PHARMACEUTICAL INDUSTRY, BY COUNTRY, 2021–2028 (USD MILLION) 120 TABLE 95 EUROPE: EMPTY CAPSULES MARKET FOR PHARMACEUTICAL INDUSTRY, BY COUNTRY, 2021–2028 (USD MILLION) 121 TABLE 96 ASIA PACIFIC: EMPTY CAPSULES MARKET FOR PHARMACEUTICAL INDUSTRY, BY COUNTRY, 2021–2028 (USD MILLION) 121 9.3 NUTRACEUTICAL INDUSTRY 121 9.3.1 INCREASING DEMAND FOR DIETARY SUPPLEMENTS IN DEVELOPED AND DEVELOPING COUNTRIES TO SUPPORT GROWTH 121 TABLE 97 EMPTY CAPSULES MARKET FOR NUTRACEUTICAL INDUSTRY, BY REGION, 2021–2028 (USD MILLION) 122 TABLE 98 NORTH AMERICA: EMPTY CAPSULES MARKET FOR NUTRACEUTICAL INDUSTRY, BY COUNTRY, 2021–2028 (USD MILLION) 122 TABLE 99 EUROPE: EMPTY CAPSULES MARKET FOR NUTRACEUTICAL INDUSTRY, BY COUNTRY, 2021–2028 (USD MILLION) 123 TABLE 100 ASIA PACIFIC: EMPTY CAPSULES MARKET FOR NUTRACEUTICAL INDUSTRY, BY COUNTRY, 2021–2028 (USD MILLION) 123 9.4 COSMETICS INDUSTRY 123 9.4.1 GELATIN-BASED CAPSULES ARE IDEAL FOR DELIVERING COSMETIC PRODUCTS 123 TABLE 101 EMPTY CAPSULES MARKET FOR COSMETICS INDUSTRY, BY REGION, 2021–2028 (USD MILLION) 124 TABLE 102 NORTH AMERICA: EMPTY CAPSULES MARKET FOR COSMETICS INDUSTRY, BY COUNTRY, 2021–2028 (USD MILLION) 124 TABLE 103 EUROPE: EMPTY CAPSULES MARKET FOR COSMETICS INDUSTRY, BY COUNTRY, 2021–2028 (USD MILLION) 125 TABLE 104 ASIA PACIFIC: EMPTY CAPSULES MARKET FOR COSMETICS INDUSTRY, BY COUNTRY, 2021–2028 (USD MILLION) 125 9.5 RESEARCH LABORATORIES 125 9.5.1 RISING CLINICAL TRIAL ACTIVITY TO DRIVE MARKET GROWTH 125 TABLE 105 EMPTY CAPSULES MARKET FOR RESEARCH LABORATORIES, BY REGION, 2021–2028 (USD MILLION) 126 TABLE 106 NORTH AMERICA: EMPTY CAPSULES MARKET FOR RESEARCH LABORATORIES, BY COUNTRY, 2021–2028 (USD MILLION) 126 TABLE 107 EUROPE: EMPTY CAPSULES MARKET FOR RESEARCH LABORATORIES, BY COUNTRY, 2021–2028 (USD MILLION) 127 TABLE 108 ASIA PACIFIC: EMPTY CAPSULES MARKET FOR RESEARCH LABORATORIES, BY COUNTRY, 2021–2028 (USD MILLION) 127 10 EMPTY CAPSULES MARKET, BY REGION 128 10.1 INTRODUCTION 129 TABLE 109 EMPTY CAPSULES MARKET, BY REGION, 2021–2028 (USD MILLION) 129 TABLE 110 EMPTY CAPSULES MARKET, BY REGION, 2021–2028 (BILLION UNITS) 129 10.2 NORTH AMERICA 130 FIGURE 26 NORTH AMERICA: EMPTY CAPSULES MARKET SNAPSHOT 131 TABLE 111 NORTH AMERICA: EMPTY CAPSULES MARKET, BY COUNTRY, 2021–2028 (USD MILLION) 131 TABLE 112 NORTH AMERICA: EMPTY CAPSULES MARKET, BY TYPE, 2021–2028 (USD MILLION) 132 TABLE 113 NORTH AMERICA: GELATIN CAPSULES MARKET, BY TYPE, 2021–2028 (USD MILLION) 132 TABLE 114 NORTH AMERICA: NON-GELATIN CAPSULES MARKET, BY TYPE, 2021–2028 (USD MILLION) 132 TABLE 115 NORTH AMERICA: EMPTY CAPSULES MARKET, BY FUNCTIONALITY, 2021–2028 (USD MILLION) 133 TABLE 116 NORTH AMERICA: EMPTY CAPSULES MARKET, BY THERAPEUTIC APPLICATION, 2021–2028 (USD MILLION) 133 TABLE 117 NORTH AMERICA: EMPTY CAPSULES MARKET, BY END USER, 2021–2028 (USD MILLION) 134 10.2.1 US 134 10.2.1.1 US to dominate North American market during forecast period 134 TABLE 118 US: EMPTY CAPSULES MARKET, BY TYPE, 2021–2028 (USD MILLION) 135 TABLE 119 US: GELATIN CAPSULES MARKET, BY TYPE, 2021–2028 (USD MILLION) 135 TABLE 120 US: NON-GELATIN CAPSULES MARKET, BY TYPE, 2021–2028 (USD MILLION) 135 TABLE 121 US: EMPTY CAPSULES MARKET, BY FUNCTIONALITY, 2021–2028 (USD MILLION) 136 TABLE 122 US: EMPTY CAPSULES MARKET, BY THERAPEUTIC APPLICATION, 2021–2028 (USD MILLION) 136 TABLE 123 US: EMPTY CAPSULES MARKET, BY END USER, 2021–2028 (USD MILLION) 137 10.2.2 CANADA 137 10.2.2.1 Rising government focus on utilization of generics as means for controlling healthcare expenditure to drive growth 137 TABLE 124 CANADA: EMPTY CAPSULES MARKET, BY TYPE, 2021–2028 (USD MILLION) 138 TABLE 125 CANADA: GELATIN CAPSULES MARKET, BY TYPE, 2021–2028 (USD MILLION) 138 TABLE 126 CANADA: NON-GELATIN CAPSULES MARKET, BY TYPE, 2021–2028 (USD MILLION) 138 TABLE 127 CANADA: EMPTY CAPSULES MARKET, BY FUNCTIONALITY, 2021–2028 (USD MILLION) 139 TABLE 128 CANADA: EMPTY CAPSULES MARKET, BY THERAPEUTIC APPLICATION, 2021–2028 (USD MILLION) 139 TABLE 129 CANADA: EMPTY CAPSULES MARKET, BY END USER, 2021–2028 (USD MILLION) 140 10.2.3 NORTH AMERICA: RECESSION IMPACT 140 10.3 EUROPE 140 TABLE 130 EUROPE: EMPTY CAPSULES MARKET, BY COUNTRY, 2021–2028 (USD MILLION) 141 TABLE 131 EUROPE: EMPTY CAPSULES MARKET, BY TYPE, 2021–2028 (USD MILLION) 141 TABLE 132 EUROPE: GELATIN CAPSULES MARKET, BY TYPE, 2021–2028 (USD MILLION) 141 TABLE 133 EUROPE: NON-GELATIN CAPSULES MARKET, BY TYPE, 2021–2028 (USD MILLION) 142 TABLE 134 EUROPE: EMPTY CAPSULES MARKET, BY FUNCTIONALITY, 2021–2028 (USD MILLION) 142 TABLE 135 EUROPE: EMPTY CAPSULES MARKET, BY THERAPEUTIC APPLICATION, 2021–2028 (USD MILLION) 142 TABLE 136 EUROPE: EMPTY CAPSULES MARKET, BY END USER, 2021–2028 (USD MILLION) 143 10.3.1 GERMANY 143 10.3.1.1 Presence of large number of pharmaceutical and nutraceutical manufacturers propelling demand for empty capsules 143 TABLE 137 GERMANY: EMPTY CAPSULES MARKET, BY TYPE, 2021–2028 (USD MILLION) 144 TABLE 138 GERMANY: GELATIN CAPSULES MARKET, BY TYPE, 2021–2028 (USD MILLION) 144 TABLE 139 GERMANY: NON-GELATIN CAPSULES MARKET, BY TYPE, 2021–2028 (USD MILLION) 144 TABLE 140 GERMANY: EMPTY CAPSULES MARKET, BY FUNCTIONALITY, 2021–2028 (USD MILLION) 145 TABLE 141 GERMANY: EMPTY CAPSULES MARKET, BY THERAPEUTIC APPLICATION, 2021–2028 (USD MILLION) 145 TABLE 142 GERMANY: EMPTY CAPSULES MARKET, BY END USER, 2021–2028 (USD MILLION) 146 10.3.2 UK 146 10.3.2.1 Rising adoption of generics to drive market growth 146 TABLE 143 UK: EMPTY CAPSULES MARKET, BY TYPE, 2021–2028 (USD MILLION) 146 TABLE 144 UK: GELATIN CAPSULES MARKET, BY TYPE, 2021–2028 (USD MILLION) 147 TABLE 145 UK: NON-GELATIN CAPSULES MARKET, BY TYPE, 2021–2028 (USD MILLION) 147 TABLE 146 UK: EMPTY CAPSULES MARKET, BY FUNCTIONALITY, 2021–2028 (USD MILLION) 147 TABLE 147 UK: EMPTY CAPSULES MARKET, BY THERAPEUTIC APPLICATION, 2021–2028 (USD MILLION) 148 TABLE 148 UK: EMPTY CAPSULES MARKET, BY END USER, 2021–2028 (USD MILLION) 148 10.3.3 FRANCE 148 10.3.3.1 High demand for pharmaceutical products to drive market growth 148 TABLE 149 FRANCE: EMPTY CAPSULES MARKET, BY TYPE, 2021–2028 (USD MILLION) 149 TABLE 150 FRANCE: GELATIN CAPSULES MARKET, BY TYPE, 2021–2028 (USD MILLION) 149 TABLE 151 FRANCE: NON-GELATIN CAPSULES MARKET, BY TYPE, 2021–2028 (USD MILLION) 150 TABLE 152 FRANCE: EMPTY CAPSULES MARKET, BY FUNCTIONALITY, 2021–2028 (USD MILLION) 150 TABLE 153 FRANCE: EMPTY CAPSULES MARKET, BY THERAPEUTIC APPLICATION, 2021–2028 (USD MILLION) 150 TABLE 154 FRANCE: EMPTY CAPSULES MARKET, BY END USER, 2021–2028 (USD MILLION) 151 10.3.4 ITALY 151 10.3.4.1 Growing presence of small and medium-sized CMOs likely to drive market 151 TABLE 155 ITALY: EMPTY CAPSULES MARKET, BY TYPE, 2021–2028 (USD MILLION) 152 TABLE 156 ITALY: GELATIN CAPSULES MARKET, BY TYPE, 2021–2028 (USD MILLION) 152 TABLE 157 ITALY: NON-GELATIN CAPSULES MARKET, BY TYPE, 2021–2028 (USD MILLION) 152 TABLE 158 ITALY: EMPTY CAPSULES MARKET, BY FUNCTIONALITY, 2021–2028 (USD MILLION) 153 TABLE 159 ITALY: EMPTY CAPSULES MARKET, BY THERAPEUTIC APPLICATION, 2021–2028 (USD MILLION) 153 TABLE 160 ITALY: EMPTY CAPSULES MARKET, BY END USER, 2021–2028 (USD MILLION) 154 10.3.5 SPAIN 154 10.3.5.1 Consolidation of biotechnology sector and availability of government support to drive growth 154 TABLE 161 SPAIN: EMPTY CAPSULES MARKET, BY TYPE, 2021–2028 (USD MILLION) 154 TABLE 162 SPAIN: GELATIN CAPSULES MARKET, BY TYPE, 2021–2028 (USD MILLION) 155 TABLE 163 SPAIN: NON-GELATIN CAPSULES MARKET, BY TYPE, 2021–2028 (USD MILLION) 155 TABLE 164 SPAIN: EMPTY CAPSULES MARKET, BY FUNCTIONALITY, 2021–2028 (USD MILLION) 155 TABLE 165 SPAIN: EMPTY CAPSULES MARKET, BY THERAPEUTIC APPLICATION, 2021–2028 (USD MILLION) 156 TABLE 166 SPAIN: EMPTY CAPSULES MARKET, BY END USER, 2021–2028 (USD MILLION) 156 10.3.6 REST OF EUROPE 156 TABLE 167 REST OF EUROPE: EMPTY CAPSULES MARKET, BY TYPE, 2021–2028 (USD MILLION) 157 TABLE 168 REST OF EUROPE: GELATIN CAPSULES MARKET, BY TYPE, 2021–2028 (USD MILLION) 157 TABLE 169 REST OF EUROPE: NON-GELATIN CAPSULES MARKET, BY TYPE, 2021–2028 (USD MILLION) 158 TABLE 170 REST OF EUROPE: EMPTY CAPSULES MARKET, BY FUNCTIONALITY, 2021–2028 (USD MILLION) 158 TABLE 171 REST OF EUROPE: EMPTY CAPSULES MARKET, BY THERAPEUTIC APPLICATION, 2021–2028 (USD MILLION) 159 TABLE 172 REST OF EUROPE: EMPTY CAPSULES MARKET, BY END USER, 2021–2028 (USD MILLION) 159 10.3.7 EUROPE: RECESSION IMPACT 159 10.4 ASIA PACIFIC 160 FIGURE 27 ASIA PACIFIC: EMPTY CAPSULES MARKET SNAPSHOT 161 TABLE 173 ASIA PACIFIC: EMPTY CAPSULES MARKET, BY COUNTRY, 2021–2028 (USD MILLION) 161 TABLE 174 ASIA PACIFIC: EMPTY CAPSULES MARKET, BY TYPE, 2021–2028 (USD MILLION) 162 TABLE 175 ASIA PACIFIC: GELATIN CAPSULES MARKET, BY TYPE, 2021–2028 (USD MILLION) 162 TABLE 176 ASIA PACIFIC: NON-GELATIN CAPSULES MARKET, BY TYPE, 2021–2028 (USD MILLION) 162 TABLE 177 ASIA PACIFIC: EMPTY CAPSULES MARKET, BY FUNCTIONALITY, 2021–2028 (USD MILLION) 163 TABLE 178 ASIA PACIFIC: EMPTY CAPSULES MARKET, BY THERAPEUTIC APPLICATION, 2021–2028 (USD MILLION) 163 TABLE 179 ASIA PACIFIC: EMPTY CAPSULES MARKET, BY END USER, 2021–2028 (USD MILLION) 164 10.4.1 CHINA 164 10.4.1.1 Low manufacturing costs on account of availability of raw materials to accelerate growth 164 TABLE 180 CHINA: EMPTY CAPSULES MARKET, BY TYPE, 2021–2028 (USD MILLION) 165 TABLE 181 CHINA: GELATIN CAPSULES MARKET, BY TYPE, 2021–2028 (USD MILLION) 165 TABLE 182 CHINA: NON-GELATIN CAPSULES MARKET, BY TYPE, 2021–2028 (USD MILLION) 165 TABLE 183 CHINA: EMPTY CAPSULES MARKET, BY FUNCTIONALITY, 2021–2028 (USD MILLION) 166 TABLE 184 CHINA: EMPTY CAPSULES MARKET, BY THERAPEUTIC APPLICATION, 2021–2028 (USD MILLION) 166 TABLE 185 CHINA: EMPTY CAPSULES MARKET, BY END USER, 2021–2028 (USD MILLION) 167 10.4.2 JAPAN 167 10.4.2.1 Japan to be largest market for empty capsules in Asia Pacific 167 TABLE 186 JAPAN: EMPTY CAPSULES MARKET, BY TYPE, 2021–2028 (USD MILLION) 168 TABLE 187 JAPAN: GELATIN CAPSULES MARKET, BY TYPE, 2021–2028 (USD MILLION) 168 TABLE 188 JAPAN: NON-GELATIN CAPSULES MARKET, BY TYPE, 2021–2028 (USD MILLION) 168 TABLE 189 JAPAN: EMPTY CAPSULES MARKET, BY FUNCTIONALITY, 2021–2028 (USD MILLION) 169 TABLE 190 JAPAN: EMPTY CAPSULES MARKET, BY THERAPEUTIC APPLICATION, 2021–2028 (USD MILLION) 169 TABLE 191 JAPAN: EMPTY CAPSULES MARKET, BY END USER, 2021–2028 (USD MILLION) 170 10.4.3 INDIA 170 10.4.3.1 Increased exports of empty capsules to drive market growth 170 TABLE 192 INDIA: EMPTY CAPSULES MARKET, BY TYPE, 2021–2028 (USD MILLION) 171 TABLE 193 INDIA: GELATIN CAPSULES MARKET, BY TYPE, 2021–2028 (USD MILLION) 171 TABLE 194 INDIA: NON-GELATIN CAPSULES MARKET, BY TYPE, 2021–2028 (USD MILLION) 171 TABLE 195 INDIA: EMPTY CAPSULES MARKET, BY FUNCTIONALITY, 2021–2028 (USD MILLION) 172 TABLE 196 INDIA: EMPTY CAPSULES MARKET, BY THERAPEUTIC APPLICATION, 2021–2028 (USD MILLION) 172 TABLE 197 INDIA: EMPTY CAPSULES MARKET, BY END USER, 2021–2028 (USD MILLION) 173 10.4.4 REST OF ASIA PACIFIC 173 TABLE 198 REST OF ASIA PACIFIC: EMPTY CAPSULES MARKET, BY TYPE, 2021–2028 (USD MILLION) 173 TABLE 199 REST OF ASIA PACIFIC: GELATIN CAPSULES MARKET, BY TYPE, 2021–2028 (USD MILLION) 174 TABLE 200 REST OF ASIA PACIFIC: NON-GELATIN CAPSULES MARKET, BY TYPE, 2021–2028 (USD MILLION) 174 TABLE 201 REST OF ASIA PACIFIC: EMPTY CAPSULES MARKET, BY FUNCTIONALITY, 2021–2028 (USD MILLION) 174 TABLE 202 REST OF ASIA PACIFIC: EMPTY CAPSULES MARKET, BY THERAPEUTIC APPLICATION, 2021–2028 (USD MILLION) 175 TABLE 203 REST OF ASIA PACIFIC: EMPTY CAPSULES MARKET, BY END USER, 2021–2028 (USD MILLION) 175 10.4.5 ASIA PACIFIC: RECESSION IMPACT 175 10.5 LATIN AMERICA 176 10.5.1 STRATEGIC EXPANSIONS BY LEADING MARKET PLAYERS TO DRIVE GROWTH 176 TABLE 204 LATIN AMERICA: EMPTY CAPSULES MARKET, BY TYPE, 2021–2028 (USD MILLION) 176 TABLE 205 LATIN AMERICA: GELATIN CAPSULES MARKET, BY TYPE, 2021–2028 (USD MILLION) 177 TABLE 206 LATIN AMERICA: NON-GELATIN CAPSULES MARKET, BY TYPE, 2021–2028 (USD MILLION) 177 TABLE 207 LATIN AMERICA: EMPTY CAPSULES MARKET, BY FUNCTIONALITY, 2021–2028 (USD MILLION) 177 TABLE 208 LATIN AMERICA: EMPTY CAPSULES MARKET, BY THERAPEUTIC APPLICATION, 2021–2028 (USD MILLION) 178 TABLE 209 LATIN AMERICA: EMPTY CAPSULES MARKET, BY END USER, 2021–2028 (USD MILLION) 178 10.5.2 LATIN AMERICA: RECESSION IMPACT 178 10.6 MIDDLE EAST & AFRICA 179 10.6.1 GROWING PHARMACEUTICAL INDUSTRY TO DRIVE MARKET 179 TABLE 210 MIDDLE EAST & AFRICA: EMPTY CAPSULES MARKET, BY TYPE, 2021–2028 (USD MILLION) 179 TABLE 211 MIDDLE EAST & AFRICA: GELATIN CAPSULES MARKET, BY TYPE, 2021–2028 (USD MILLION) 180 TABLE 212 MIDDLE EAST & AFRICA: NON-GELATIN CAPSULES MARKET, BY TYPE, 2021–2028 (USD MILLION) 180 TABLE 213 MIDDLE EAST & AFRICA: EMPTY CAPSULES MARKET, BY FUNCTIONALITY, 2021–2028 (USD MILLION) 180 TABLE 214 MIDDLE EAST & AFRICA: EMPTY CAPSULES MARKET, BY THERAPEUTIC APPLICATION, 2021–2028 (USD MILLION) 181 TABLE 215 MIDDLE EAST & AFRICA: EMPTY CAPSULES MARKET, BY END USER, 2021–2028 (USD MILLION) 181 10.6.2 MIDDLE EAST & AFRICA: RECESSION IMPACT 182 11 COMPETITIVE LANDSCAPE 183 11.1 INTRODUCTION 183 11.2 RIGHT-TO-WIN APPROACHES ADOPTED BY KEY PLAYERS 183 FIGURE 28 EMPTY CAPSULES MARKET: STRATEGIES ADOPTED 184 11.3 MARKET SHARE ANALYSIS 185 FIGURE 29 EMPTY CAPSULES MARKET: MARKET SHARE ANALYSIS, BY KEY PLAYER (2022) 185 TABLE 216 EMPTY CAPSULES MARKET: DEGREE OF COMPETITION 185 11.4 REVENUE ANALYSIS 187 FIGURE 30 REVENUE ANALYSIS FOR KEY COMPANIES (2020–2022) 187 11.5 COMPANY EVALUATION MATRIX 187 11.5.1 STARS 187 11.5.2 EMERGING LEADERS 187 11.5.3 PERVASIVE PLAYERS 187 11.5.4 PARTICIPANTS 188 FIGURE 31 EMPTY CAPSULES MARKET: COMPANY EVALUATION MATRIX, 2022 188 11.6 COMPANY EVALUATION MATRIX FOR START-UPS/SMES 189 11.6.1 PROGRESSIVE COMPANIES 189 11.6.2 STARTING BLOCKS 189 11.6.3 RESPONSIVE COMPANIES 189 11.6.4 DYNAMIC COMPANIES 189 FIGURE 32 EMPTY CAPSULES MARKET: COMPANY EVALUATION MATRIX FOR START-UPS/SMES, 2022 190 11.7 COMPETITIVE BENCHMARKING OF TOP 25 PLAYERS 191 11.7.1 OVERALL COMPANY FOOTPRINT (25 COMPANIES) 191 TABLE 217 OVERALL FOOTPRINT ANALYSIS OF KEY PLAYERS 191 11.7.2 INDUSTRY FOOTPRINT OF COMPANIES (25 COMPANIES) 192 TABLE 218 INDUSTRY FOOTPRINT ANALYSIS OF KEY PLAYERS 192 11.7.3 REGIONAL FOOTPRINT OF COMPANIES (25 COMPANIES) 193 TABLE 219 REGIONAL FOOTPRINT ANALYSIS OF KEY PLAYERS 193 11.7.4 OFFERING FOOTPRINT OF COMPANIES (25 COMPANIES) 194 TABLE 220 OFFERING FOOTPRINT ANALYSIS OF KEY PLAYERS 194 11.8 COMPETITIVE BENCHMARKING OF START-UPS/SMES 195 TABLE 221 EMPTY CAPSULES MARKET: DETAILED LIST OF KEY START-UPS/SMES 195 TABLE 222 EMPTY CAPSULES MARKET: COMPETITIVE BENCHMARKING OF START-UPS/SMES 196 11.9 COMPETITIVE SCENARIO AND TRENDS 196 11.9.1 PRODUCT LAUNCHES 196 TABLE 223 EMPTY CAPSULES MARKET: PRODUCT LAUNCHES, JANUARY 2020–MARCH 2023 196 11.9.2 DEALS 197 TABLE 224 EMPTY CAPSULES MARKET: DEALS, JANUARY 2020–MARCH 2023 197 11.9.3 OTHER DEVELOPMENTS 197 TABLE 225 EMPTY CAPSULES MARKET: OTHER DEVELOPMENTS, JANUARY 2020–MARCH 2023 197
ご注文は、お電話またはWEBから承ります。お見積もりの作成もお気軽にご相談ください。本レポートと同分野の最新刊レポート
MarketsandMarkets社のPharmaceuticals分野での最新刊レポート
本レポートと同じKEY WORD(gelatin)の最新刊レポート
よくあるご質問MarketsandMarkets社はどのような調査会社ですか?マーケッツアンドマーケッツ(MarketsandMarkets)は通信、半導体、医療機器、エネルギーなど、幅広い市場に関する調査レポートを出版しています。また広範な市場を対象としたカスタム調査も行って... もっと見る 調査レポートの納品までの日数はどの程度ですか?在庫のあるものは速納となりますが、平均的には 3-4日と見て下さい。
注文の手続きはどのようになっていますか?1)お客様からの御問い合わせをいただきます。
お支払方法の方法はどのようになっていますか?納品と同時にデータリソース社よりお客様へ請求書(必要に応じて納品書も)を発送いたします。
データリソース社はどのような会社ですか?当社は、世界各国の主要調査会社・レポート出版社と提携し、世界各国の市場調査レポートや技術動向レポートなどを日本国内の企業・公官庁及び教育研究機関に提供しております。
|
詳細検索
2025/04/03 10:27 148.83 円 162.56 円 196.84 円 |